0001144204-11-025461.txt : 20110502
0001144204-11-025461.hdr.sgml : 20110502
20110502163247
ACCESSION NUMBER: 0001144204-11-025461
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110502
FILED AS OF DATE: 20110502
DATE AS OF CHANGE: 20110502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PETERSON PETER M
CENTRAL INDEX KEY: 0001260044
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-72097
FILM NUMBER: 11801149
MAIL ADDRESS:
STREET 1: 204 NW PLATTE VALLEY DRIVE
CITY: RIVERSIDE
STATE: MO
ZIP: 64150
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201
STREET 2: SUITE 201
CITY: NAPLES
STATE: FL
ZIP: 34108
BUSINESS PHONE: 9419231949
MAIL ADDRESS:
STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201
STREET 2: SUITE 201
CITY: NAPLES
STATE: FL
ZIP: 34108
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
3
1
form319158_050211163122-.xml
X0203
3
2011-05-02
0
0001077183
NEOGENOMICS INC
NGNM.OB
0001260044
PETERSON PETER M
C/O NEOGENOMICS, INC.
12701 COMMONWEALTH DRIVE, SUITE 9
FORT MYERS
FL
US 33913
1
0
1
0
Common Stock
8038123
I
By Aspen Select Healthcare, LP
Common Stock
129427
I
By Aspen Opportunity Fund, LP
Common Stock
24000
D
Warrant (Right to Buy)
1.5
2007-06-07
2012-06-07
Common Stock
100000
D
Warrant (Right to Buy)
0.75
2009-02-09
2014-02-09
Common Stock
83333
I
By Gulf Pointe Capital, LLC
Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Peterson is a Managing Member of Medical Venture Partners, LLC. Mr. Peterson disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
An investment entity controlled by Peter Peterson. Mr. Peterson disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
On April 27, 2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Peterson remains a Director of the Company.
/s/ Peter M. Peterson
2011-05-02